Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Long-Term Investments: 2010-2021

Historic Long-Term Investments for Neurocrine Biosciences (NBIX) over the last 10 years, with Sep 2021 value amounting to $513.7 million.

  • Neurocrine Biosciences' Long-Term Investments rose 183.19% to $513.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $513.7 million, marking a year-over-year increase of 183.19%. This contributed to the annual value of $227.1 million for FY2020, which is 24.22% down from last year.
  • Neurocrine Biosciences' Long-Term Investments amounted to $513.7 million in Q3 2021, which was up 52.07% from $337.8 million recorded in Q2 2021.
  • In the past 5 years, Neurocrine Biosciences' Long-Term Investments ranged from a high of $513.7 million in Q3 2021 and a low of $37.7 million during Q1 2017.
  • In the last 3 years, Neurocrine Biosciences' Long-Term Investments had a median value of $227.1 million in 2020 and averaged $251.7 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first skyrocketed by 657.11% in 2017, then plummeted by 41.25% in 2019.
  • Over the past 5 years, Neurocrine Biosciences' Long-Term Investments (Quarterly) stood at $247.4 million in 2017, then decreased by 12.67% to $216.0 million in 2018, then surged by 38.73% to $299.7 million in 2019, then fell by 24.22% to $227.1 million in 2020, then soared by 183.19% to $513.7 million in 2021.
  • Its last three reported values are $513.7 million in Q3 2021, $337.8 million for Q2 2021, and $249.6 million during Q1 2021.